Company Name, Ticker, Industry, else..

Revance Therapeutics Inc (RVNC)

Other Ticker:

Sector • Healthcare Industry • Major Pharmaceutical Preparations

Industry • Major Pharmaceutical Preparations

Sector • Healthcare

Revance Therapeutics Inc

RVNC's Fundamental analysis

Select the Comparisons :

None ▼

Select the Ratio:

None▼

None ▼

None▼

RVNC Growth rates comparisons

Looking into Revance Therapeutics Inc growth rates, revenue grew by 92.37 % in IV. Quarter 2022 from the same quarter a year ago. Ranking at No. 634

Major Pharmaceutical Preparations industry recorded deterioration of revenues by -3.79 %

Revance Therapeutics Inc realized net income compared to net loss a year ago in IV. Quarter 2022

• More on RVNC's Growth

RVNC's Valuation comparisons

Revance Therapeutics Inc
realized net loss in trailing twelve months.

Revance Therapeutics Inc realized cash outflow of $ -0.01per share in trailing twelve-month period.

Company

-

PE TTM

Industry

0.01

PE TTM

Company's Price to Sales ratio is at 17.39.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.47.

• More on RVNC's Valuation

Total Debt (Millions $)	379
Dividend TTM ($)	0 $
Dividend Yield TTM (%)	-
Revenue/Employee (TTM) $	-
Net Income/Employee (TTM) $	-
Receivable Turnover (TTM)	16
Tangible Book Value (Per Share $)	-1.26

RVNC's Valuation comparisons

Revance Therapeutics Inc
realized net loss in trailing twelve months.

Revance Therapeutics Inc realized cash outflow of $ -0.01per share in trailing twelve-month period.

Company

-

PE TTM

Industry

0.01

PE TTM

Company's Price to Sales ratio is at 17.39.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.47.

Revance Therapeutics Inc Price to Book Ratio is at 183 higher than Indusry Avg. of 0.03, and higher than S&P 500 Avg. of -0.01

• More on RVNC's Valuation

• Market Capitalization (Millions $)	2,306
• Shares Outstanding (Millions)	73
• Employees	-
• Revenues (TTM) (Millions $)	133
• Net Income (TTM) (Millions $)	-1
• Cash Flow (TTM) (Millions $)	-1
• Capital Exp. (TTM) (Millions $)	-3
• Total Debt (Millions $)	379
• Dividend TTM ($)	0 $
• Dividend Yield TTM (%)	-
• Revenue/Employee (TTM) $	-
• Net Income/Employee(TTM) $	-
• Receivable Turnover Ratio (TTM)	16
• Tangible Book Value (Per Share $)	-1.26

• Market Capitalization (Millions $)	2,306
• Shares Outstanding (Millions)	73
• Employees	-
• Revenues (TTM) (Millions $)	133
• Net Income (TTM) (Millions $)	-1
• Cash Flow (TTM) (Millions $)	-1
• Capital Exp. (TTM) (Millions $)	-3

	*Ratio*
• Capital Ratio (MRQ)	4.95
• Total Debt to Equity (MRQ)	30.11
• Tangible Leverage Ratio (MRQ)	-
• Asset Turnover Ratio (TTM)	0.21
• Inventory Turnover Ratio (TTM)	2.97

RVNC's Profitability Comparisons

Revance Therapeutics Inc net profit margin of 251.95 % is currently ranking no. 8 in Major Pharmaceutical Preparations industry, ranking no. 15 in Healthcare sector and number 50 in S&P 500.

• More on RVNC's Key Ratios


Economy Advance Monthly Sales Consumer Price Index CPI Producer Price Index PPI Retail Inventories Personal Income Gross Domestic Product GDP Money Supply Industrial Production Productivity Employment Situation US International Trade Factory Orders Durable Goods Construction Spending Housing Starts Vehicle Unit Sales	Stocks Event Calendar NUVL's Profile Stock Price NUVL's Financials Business Description Fundamentals Charts & Quotes NUVL's News Suppliers NUVL's Competitors Customers & Markets Economic Indicators NUVL's Growth Company Segments	Screening Stock Performance Growth Rates Profitability Valuation Dividend Financial Strength Efficiency Largest Companies Management Effectivness

Help

Sitemap

Advertise

About us

Glossary

Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071